Schizophrenia Care in Rural America - Innovative Strategies for Improving Adherence and Outcomes in Community Mental Health Centers is organized by Boston University School of Medicine Continuing Medical Education (BUSM CME).
Release: Jul 2, 2018
Expires: Jul 1, 2019
This program is designed specifically for mental health professionals practicing in a rural health setting who are involved in the care of patients with schizophrenia and schizoaffective disorders.
Boston University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact Hours: 1.0 of which 1.0 are eligible for pharmacology credit.
Schizophrenia is a chronic, heterogeneous, and progressively disabling mental illness characterized by frequent relapses, persistence of symptoms, and substantial functional deficits.Despite pharmacologic advances, the treatment of schizophrenia remains a challenge and outcomes remain suboptimal.Major gaps in practice are evident at each point on the care continuum, including underuse of measurement-based approaches, inadequate treatment in the acute and maintenance phases, and poor medication adherence.Rural settings present unique challenges to management of schizophrenia as patients have limited access to mental health providers in addition to geographic and financial barriers to care. This online educational activity is designed to help mental health providers practicing in rural settings overcome barriers and achieve better outcomes for their patients with schizophrenia. Expert faculty will discuss the safety and efficacy of currently available antipsychotic agents, strategies for individualizing treatment and monitoring symptoms, and the role of long-acting injectables for promoting medication adherence.
• Apply current guideline recommendations and available data to individualize treatment for patients with schizophrenia.
• Review the mechanisms of action, safety, and efficacy of antipsychotic treatments for schizophrenia.
• Use measurement-based strategies and tools to assess and manage patients with schizophrenia.
• Evaluate nonpharmacologic and pharmacologic strategies for improving medication adherence in patients with schizophrenia.
Additional details will be posted as soon as they are available.